Trigger for impairment testing
Many countries are implementing stringent measures to contain the spread of the COVID-19 coronavirus. These measures have significantly affected economic activity and sentiment, disrupting the business operations of companies worldwide – particularly those that:
The rapid deterioration in the economic environment and the increase in uncertainty in the macroeconomic and business outlook have triggered a sharp fall in stock markets worldwide accompanied by significant fluctuations in foreign exchange rates and commodity prices. As a result, the likelihood that a triggering event has occurred in the first quarter of 2020 and therefore that an impairment test is required has increased significantly, including for assets that are required to be tested for impairment annually.
Challenges in estimating cash flows
When a triggering event has occurred, management needs to determine the recoverable amount (the higher of VIU and FVLCD1 ) of an asset or cash-generating unit (CGU), which usually requires management to forecast future cash flows. Budgets and cash flow forecasts prepared by management generally serve as the starting point for the discounted cash flows used in calculating the recoverable amount. Significant assumptions, such as forecast sales volumes, prices, gross margins, changes in working capital, foreign exchange rates and discount rates will need to be reassessed and updated as appropriate due to the significant changes in economic and market conditions. Cash flows used in determining FVLCD should be updated to reflect the assumptions that market participants would use based on market conditions and information available at the reporting date. [IAS 36.4, 9, 33, IFRS 13.2]
Making the estimate could be challenging given the degree of uncertainty about:
Reflecting risks in the discount rate
The discount rate used to discount the forecast cash flows under both VIU and FVLCD might be significantly affected by COVID-19 due to the increase in uncertainty and risks. The discount rate should reflect the impact of changes in interest rates and the risk environment at the reporting date. [IAS 36.56]
Disruptions to business operations and increased economic uncertainty due to COVID-19 may trigger the need to perform impairment testing in the first quarter of 2020. Estimating future cash flows to calculate the recoverable amount will be challenging given the high level of uncertainty.
Trigger for impairment testing
IAS 36 Impairment of Assets applies to a variety of non-financial assets including property, plant and equipment, right-of-use assets, intangible assets and goodwill, investment properties measured at cost and investments in associates and joint ventures2. [IAS 36.2, 4]
IAS 36 requires goodwill and indefinite-lived intangible assets to be tested for impairment at least annually and other non-financial assets when there is an indication of possible impairment (a triggering event). It provides examples of indicators of triggering events, including:
The impacts of COVID-19 have caused a significant deterioration in economic conditions for many companies, and an increase in economic uncertainty for others, which may constitute triggering events.
Challenges in estimating cash flows
Estimating future cash flows could be particularly challenging for many companies due to the increase in economic uncertainty.
Due to the high degree of uncertainty and resulting challenges in forecasting cash flows, it could be helpful to base those forecasts on external sources such as economic projections by respected central banks and other international organisations.
To cushion the economic and financial market impacts, governments in certain regions and international organisations have committed to fiscal stimulus, liquidity provisions and financial support. Companies will need to understand the terms and status of these provisions and consider what impact they might have on their cash flow projections.
Reflecting risks in the discount rate
COVID-19 might have a significant impact on the risk-free rate and on entity-specific risk premiums (e.g. financing risk, country risk and forecasting risk) used in determining the appropriate discount rate to discount future cash flows. [IAS 36.A1, A16, A18]
The risk-free rate is generally based on the yield on government bonds that have the same or similar duration as the cash flows of the asset or CGU. In certain jurisdictions, the yield on long-term government bonds has decreased in the first quarter of 2020. However, a decrease in the risk-free rate following a decrease in the yield on government bonds may not translate into declines in a company’s discount rate due to possible increases in credit and/or other risk premiums in the company’s circumstances. [Insights 3.10.300.120]
For more information on the impact of COVID-19 on discount rates, see our web article on fair value measurement.
Considering the approach to projecting cash flows
Given the uncertain macroeconomic outlook, with scenarios ranging from economic disruption for a few months before economic activity returns to normal, through to a lengthy period of disruption triggering a significant recession, estimation uncertainty will be significantly higher than normal and there will probably be a wider range of reasonably possible cash flow projections.
Two approaches can be used to project cash flows:
Given the high degree of uncertainty, it may be helpful to consider using an expected cash flow approach as opposed to the traditional approach. Under the traditional approach, cash flows are not adjusted for risk but, rather, risk is reflected in determining the discount rate. Under the expected cash flow approach, the uncertainty about the future cash flows is reflected in the different probability-weighted cash flow projections used, rather than in the discount rate. The expected cash flow approach inherently requires a more explicit consideration of the wider than normal range of possible future outcomes. [IFRS 13.B26, IAS 36.A7, Insights 3.10.220]
Whichever approach a company adopts, the rate used to discount cash flows should not reflect adjustments for factors that have been incorporated into the estimated cash flows and vice versa. Otherwise, the effect of some factors will be double counted. [IAS 36.55–56]
Impact on useful life and residual value
If recent events have changed the company’s usage or retention strategy for any of its property, plant and equipment, then management should review whether the useful life and residual value of these assets, and the depreciation method applied to them, remains appropriate. This review may also be required after testing a CGU or an asset for impairment. Any such changes are accounted for prospectively as a change in accounting estimate. [IAS 16.61, Insights 3.10.350.30]
In the context of impairment testing of goodwill and indefinite-lived intangible assets, IAS 36 requires disclosure of the key assumptions used to determine the recoverable amount. It also requires sensitivity disclosures if a reasonably possible change in a key assumption would cause the CGU’s carrying amount to exceed its recoverable amount. Furthermore, IAS 1 Presentation of Financial Statements requires disclosure of the key assumptions that a company makes about the future and other major sources of estimation uncertainty at the reporting date that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities in the next financial year. [IAS 1.125, 129, 36.134(d)–(f)]
Because the uncertainty associated with management’s assumptions about the future is likely to be significant, it is important that management develops robust disclosures to help users understand the degree of estimation uncertainty that exists in estimating the recoverable amount and the sensitivity of the recoverable amount to reasonably possible changes to key assumptions. For example, it may be appropriate to disclose management’s views about the degree of uncertainty associated with the macroeconomic outlook (such as the severity and duration of the impact that COVID-19 is expected to have on the company’s business) and/or the potential significance of disruption to the supply chain, factory shutdowns, fall in demand etc.
Interim condensed reports
IAS 34 Interim Financial Reporting requires disclosure of the nature and amount of changes in estimates. Impairment losses are examples of events and transactions that require disclosure under IAS 34 if they are significant. As noted in IAS 34, when an event or transaction is significant to an understanding of the changes in an entity's financial position or performance since the last annual reporting period, as may be the case with material impairment losses recognized in an interim period, the company’s interim financial report should provide an explanation of and an update to the relevant information included in the financial statements of the last annual reporting period. IAS 36 provides relevant disclosures to be considered in this regard. [IAS 34.15B(b), 15C, 16A(d)]
Consider whether there are any indicators of impairment for the company’s CGUs or assets that are tested on a stand-alone basis. In particular, assess:
Consider whether budgets and cash flow projections reflect the following to the extent applicable to the company, based on information available at the reporting date:
Consider whether discount rates used in recent valuations have been updated to reflect the risk environment at the reporting date.
Consider enhancing sensitivity disclosures and disclosures about the key assumptions and major sources of estimation uncertainty in the interim and annual reports.
Our annual Guides to financial statements, which help you to prepare financial statements in accordance with IFRS® Standards, this year include a COVID-19 supplement illustrating additional disclosures that entities may need to provide on accounting issues arising from the pandemic.
1 VIU: value in use; FVLCD: fair value less costs of disposal.
2 The guidance in IAS 28 Investments in Associates and Joint Ventures is used to determine whether it is necessary to perform an impairment test for investments in equity-accounted investees. If there is an indication of impairment, then the impairment test follows the principles of IAS 36. [IAS 28.40-42]
References to ‘Insights’ mean our publication Insights into IFRS
© 2020 KPMG IFRG Limited is a UK company, limited by guarantee. All rights reserved. KPMG IFRG Limited, registered in England No 5253019. Registered office: 15 Canada Square, London, E14 5GL, UK.
KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.